跳至主要内容
临床试验/NCT02147769
NCT02147769已完成不适用

Cerebral Oxygenation and Autoregulation in Preterm Infants: Association With Morbidity and Mortality

Stanford University7 个研究点 分布在 1 个国家目标入组 111 人开始时间: 2014年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
111
试验地点
7
主要终点
Mortality Before Hospital Discharge

研究概览

简要总结

Premature infants are at high risk for variations in blood pressure and oxygenation during the first few days of life. The immaturity of the premature brain may further predispose these infants to death or the development of neurologic problems. The relationship between unstable blood pressure and oxygen levels and brain injury has not been well elucidated.

This study investigates the utility of near-infrared spectroscopy (NIRS), a non-invasive oxygen-measuring device, to identify preterm infants at highest risk for brain injury or death.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 24 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • birth weight <= 1250 grams
  • indwelling arterial catheter in place
  • age <24 hours old

排除标准

  • lethal chromosomal abnormality
  • major congenital anomaly
  • skin integrity insufficient to allow placement of NIRS sensors
  • decision to not provide full intensive care

结局指标

主要结局

Mortality Before Hospital Discharge

时间窗: Outcome measure will be assessed at the time of subject's initial discharge from the hospital (on average by 40 weeks postmenstrual age), but at a maximum of 1 year of life.

Participants will be followed for the outcome of death prior to hospital discharge.

Severe Central Nervous System (CNS) Morbidity

时间窗: Outcome measure will be assessed on day 10 of life. Participants will be followed for neuroradiographic evidence of CNS morbidity in the first ten days of life

Routine cranial ultrasound obtained within the first ten days of life will be utilized to detect grade 3 or 4 intraventricular hemorrhage, periventricular leukomalacia, significant ventriculomegaly, or white matter abnormalities.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Valerie Chock, M.D., M.S. Epi

Principle Investigator

Stanford University

研究点 (7)

Loading locations...

相似试验